BeeKeeperAI and Intel: Disease spotting and data protection in healthcare
Intel and BeeKeeperAI are at the forefront of healthcare innovation, upgrading data security and personalized patient care. BeeKeeperAI’s privacy-enhancing technology platform leverages Intel's confidential computing and Software Guard Extensions (SGX), to create a zero-trust environment that protects patient information while enabling precise disease identification and individualized treatment.
Advancing the future of secure data handling and disease identification in the medical industry
BeeKeeperAI uses Intel® Confidential Computing and Software Guard Extensions to protect medical information and intellectual property from cyber-attacks while allowing for disease pinpointing and curative collaboration.
In the fast-evolving landscape of healthcare, ensuring data security and privacy is paramount. Intel Confidential Computing, in collaboration with BeeKeeperAI, has pioneered a groundbreaking solution that not only protects patient information but also enables medical teams to identify diseases with unprecedented precision.
BeeKeeperAI, serves as a privacy-enhancing technology collaboration platform that allows multiple parties in the healthcare ecosystem to work together seamlessly while ensuring the confidentiality of both data and algorithms. In a world where cyber threats to health systems are on the rise, BeeKeeperAI provides a zero-trust environment, safeguarding patient privacy and data sovereignty.
The heart of BeeKeeperAI's innovative solution lies in its EscrowAI, a hive equipped with Intel® Xeon® Scalable processors, SGX, and confidential computing. This powerful combination not only facilitates data computation but also creates an impenetrable barrier against potential cyber attacks.
MaryBeth Chalk, BeeKeeperAI Co-founder and Chief Commercial Officer emphasizes the significance of individualized patient treatment, moving away from the one-size-fits-all approach, which is what BeeKeeperAI brings to the table. This new technology enables healthcare providers to compute on patient data without compromising its security, allowing for personalized disease discovery and prognosis.
MaryBeth shares her own experience with early-stage cancer detection, underscoring the importance of innovation in healthcare. BeeKeeperAI's technology holds the promise of ensuring that luck plays no part in early-stage disease identification, offering hope to countless individuals who may benefit from early intervention.
Thanks to grant funding from Intel, BeeKeeperAI successfully demonstrated the applicability of confidential computing in healthcare. This proof of concept is a testament to the commitment of both Intel and BeeKeeperAI to innovate and secure the future of healthcare data.
The collaboration comes at a crucial time, as highlighted by Mike Berger, the former Chief Data and Analytics Officer at Mount Sinai Health Partners. The increasing volume of data science and artificial intelligence in healthcare demands a reliable and secure platform. BeeKeeperAI's vision aligns with the industry's needs, aiming for disease prevention and timely, targeted treatments.
As healthcare enters an era of rapid innovation, the Intel and BeeKeeperAI collaboration stands out as a beacon of progress, ensuring data security while advancing personalized and effective patient care.
Learn how to make AI work for your organization.